IN2014MN02539A - - Google Patents
Info
- Publication number
- IN2014MN02539A IN2014MN02539A IN2539MUN2014A IN2014MN02539A IN 2014MN02539 A IN2014MN02539 A IN 2014MN02539A IN 2539MUN2014 A IN2539MUN2014 A IN 2539MUN2014A IN 2014MN02539 A IN2014MN02539 A IN 2014MN02539A
- Authority
- IN
- India
- Prior art keywords
- features
- vivo
- favorable
- analogues
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
- C07H5/06—Aminosugars
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261656265P | 2012-06-06 | 2012-06-06 | |
PCT/US2013/044285 WO2013184780A1 (en) | 2012-06-06 | 2013-06-05 | Novel iminosugars and their applications |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02539A true IN2014MN02539A (es) | 2015-07-24 |
Family
ID=49712581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2539MUN2014 IN2014MN02539A (es) | 2012-06-06 | 2013-06-05 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8921568B2 (es) |
EP (1) | EP2858642A4 (es) |
JP (1) | JP2015518896A (es) |
KR (1) | KR20150035767A (es) |
CN (1) | CN104703597A (es) |
CA (1) | CA2875975A1 (es) |
IN (1) | IN2014MN02539A (es) |
WO (1) | WO2013184780A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113425720A (zh) * | 2020-04-03 | 2021-09-24 | 深圳前海诺贝尔奖科学家技术转移转化有限公司 | 亚胺糖化合物在制备抗SARS-CoV-2病毒的药物中的用途 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6011902B2 (ja) * | 1979-12-27 | 1985-03-28 | 日本新薬株式会社 | モラノリンの誘導体 |
DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
AU732552B2 (en) | 1996-07-15 | 2001-04-26 | Genzyme Corporation | Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors |
US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
US6465487B1 (en) | 1997-12-11 | 2002-10-15 | Synergy Pharmaceuticals, Inc. | Inhibition of membrane-associated viral replication |
US6465488B1 (en) | 1997-12-11 | 2002-10-15 | Chancellor, Masters & Scholars Of The University Of Oxford | Inhibition of glycolipid biosynthesis |
US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
CA2319713C (en) | 1998-02-12 | 2012-06-26 | G.D. Searle & Co. | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
ES2311921T3 (es) | 1999-02-12 | 2009-02-16 | United Therapeutics Corporation | N-(8,8,8-trifluorooctil)1-5,-didesoxi-1,5-imino-d-glucitol para tratar infecciones por el virus de la hepatitis. |
US7256005B2 (en) | 1999-08-10 | 2007-08-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity |
JP2003506406A (ja) * | 1999-08-10 | 2003-02-18 | ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード | 長鎖n−アルキル化合物およびそのオキサ誘導体 |
AU2001236805B2 (en) * | 2000-02-11 | 2005-07-14 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
WO2001060366A1 (en) * | 2000-02-14 | 2001-08-23 | Pharmacia Corporation | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
EP1556036A2 (en) | 2002-09-23 | 2005-07-27 | The Chancellor, Masters And Scholars Of The University Of Oxford | Use of iminosugar derivatives to inhibit ion channel activity |
CA2583084C (en) * | 2003-09-19 | 2010-12-07 | Galileo Pharmaceuticals, Inc. | 7,8-bicycloalkyl-chroman derivatives |
US8481571B2 (en) * | 2004-05-04 | 2013-07-09 | Academia Sinica | Anti-coronavirus compounds |
KR100611931B1 (ko) * | 2004-09-02 | 2006-08-11 | 강경태 | 광학활성 알콕시알콜 화합물, 이로부터 유도되는 광학활성1,3-페닐렌-비스[4-(4-알콕시)페닐이미노메틸]벤조에이트화합물 및 이들의 제조방법 |
EP1865947A1 (en) * | 2005-04-04 | 2007-12-19 | Pontificia Universidad Catolica de Chile | The use of ezetimibe in the prevention and treatment of cholesterol gallstones |
CN104876855A (zh) | 2006-05-24 | 2015-09-02 | 联合治疗公司 | 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法 |
KR20090040906A (ko) | 2006-08-02 | 2009-04-27 | 유나이티드 세러퓨틱스 코오포레이션 | 바이러스 감염의 리포솜 치료 |
WO2009118658A2 (en) | 2008-03-26 | 2009-10-01 | University Of Oxford | Endoplasmic reticulum targeting liposomes |
WO2010027996A1 (en) * | 2008-09-02 | 2010-03-11 | Institute For Hepatitis And Virus Research | Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity |
JP5600329B2 (ja) | 2009-02-23 | 2014-10-01 | ユナイテッド セラピューティクス コーポレーション | イミノ糖およびウイルス性疾患を治療する方法 |
CA2753194A1 (en) | 2009-02-24 | 2010-09-02 | United Therapeutics Corporation | Iminosugars and methods of treating arenaviral infections |
EP2410989A2 (en) | 2009-03-27 | 2012-02-01 | The Chancellor, Masters and Scholars of the University of Oxford | Cholesterol level lowering liposomes |
US8426445B2 (en) | 2009-06-12 | 2013-04-23 | United Therapeutics Corporation | Iminosugars and methods of treating bunyaviral and togaviral diseases |
CN105748476A (zh) | 2009-09-04 | 2016-07-13 | 联合治疗公司 | 亚氨基糖以及治疗丝状病毒性疾病的方法 |
KR101459530B1 (ko) | 2009-09-04 | 2014-11-07 | 유나이티드 세러퓨틱스 코오포레이션 | 폭스바이러스 감염의 치료 방법 |
ES2466027T3 (es) | 2009-09-04 | 2014-06-09 | United Therapeutics Corporation | Procedimiento para el tratamiento de infecciones por ortomixovirus |
CA2783405A1 (en) | 2009-12-07 | 2011-06-16 | The Chancellor, Masters And Scholars Of The University Of Oxford | N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation |
-
2013
- 2013-06-05 WO PCT/US2013/044285 patent/WO2013184780A1/en active Application Filing
- 2013-06-05 EP EP13800188.8A patent/EP2858642A4/en not_active Withdrawn
- 2013-06-05 US US13/910,564 patent/US8921568B2/en not_active Expired - Fee Related
- 2013-06-05 IN IN2539MUN2014 patent/IN2014MN02539A/en unknown
- 2013-06-05 CA CA2875975A patent/CA2875975A1/en not_active Abandoned
- 2013-06-05 JP JP2015516166A patent/JP2015518896A/ja active Pending
- 2013-06-05 KR KR20147036446A patent/KR20150035767A/ko not_active Application Discontinuation
- 2013-06-05 CN CN201380041515.XA patent/CN104703597A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2015518896A (ja) | 2015-07-06 |
CN104703597A (zh) | 2015-06-10 |
CA2875975A1 (en) | 2013-12-12 |
US8921568B2 (en) | 2014-12-30 |
EP2858642A1 (en) | 2015-04-15 |
KR20150035767A (ko) | 2015-04-07 |
WO2013184780A1 (en) | 2013-12-12 |
EP2858642A4 (en) | 2015-12-02 |
US20130331578A1 (en) | 2013-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591662A1 (ru) | Липиды и липидные композиции для доставки активных агентов | |
NZ732777A (en) | Ionizable cationic lipid for rna delivery | |
CR20130617A (es) | Derivados de piridin-2(1h)-ona útiles como medicamentos para el tratamiento de trastornos mieloproliferativos, rechazo de trasplantes, enfermedades mediadas por el sistema inmune y enfermedades inflamatorias | |
MX2022006512A (es) | Lipidos cationicos de trialquilo y metodos de uso de los mismos. | |
UA114739C2 (uk) | Триазолопіразини | |
FR2986002A1 (fr) | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
TN2015000278A1 (en) | Autotaxin inhibitors | |
MX341332B (es) | Lipidos biodegradables para la administracion de agentes activos. | |
EA201492112A1 (ru) | ЗАМЕЩЕННЫЕ 3,4-ДИГИДРО-2H-ПИРИДО[1,2-a]ПИРАЗИН-1,6-ДИОНОВЫЕ ПРОИЗВОДНЫЕ, ПРИМЕНИМЫЕ ДЛЯ ЛЕЧЕНИЯ (В ТОМ ЧИСЛЕ) БОЛЕЗНИ АЛЬЦГЕЙМЕРА | |
TW200736234A (en) | Chemical compounds | |
IN2014DN00277A (es) | ||
MX2013000821A (es) | Nuevas aminopirazoloquinazolinas. | |
NI201500013A (es) | Tratamiento de enfermedades inmuno - relacionadas e inflamatorias. | |
EA201791727A1 (ru) | 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2-а]пиридо[3,4-е]пиримидин-5(1н)-он, его аналоги и соли и способы их применения в терапии | |
FR2977486B1 (fr) | Compositions cosmetiques sous la forme d'emulsions eau-dans-huile comprenant un derive d'acide jasmonique | |
MX357759B (es) | Formulaciones y formas de dosificacion de fosfolipidos oxidados. | |
EA201391265A1 (ru) | Амиды индолкарбоновых и бензимидазолкарбоновых кислот в качестве инсектицидов и акарицидов | |
IN2014DN01619A (es) | ||
RU2016109986A (ru) | Композиция для подавления раковых заболеваний крови или метастазирования рака, содержащая в качестве активного ингредиента моноацетилдиглицеридное соединение | |
EP3133073A3 (en) | Inhibitors of iap | |
EP2898923A3 (en) | Isoflavones for regulating sirtuin gene expression | |
EP4321218A3 (en) | Cancer stem cell targeted cancer vaccines | |
IN2014MN02539A (es) | ||
WO2011143271A3 (en) | Therapeutic liposomes and methods for producing and using the same | |
EP2815742A4 (en) | IMPROVED ADMINISTRATIVE FORM WITH EXTRACT FROM THE RINDER OF LIRIODENDRON TULIPIFERA AS AN ACTIVE SUBSTANCE |